The molecular basis of cisplatin sensitivity/resistance
- 1 January 1994
- journal article
- editorial
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (6), 725-727
- https://doi.org/10.1016/0959-8049(94)90281-x
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Deficient repair of cisplatin-DNA adducts identified in human testicular teratoma cell lines established from tumours from untreated patientsEuropean Journal Of Cancer, 1994
- New platinum antitumor complexesCritical Reviews in Oncology/Hematology, 1993
- Increased accumulation of p53 protein in cisplatin‐resistant ovarian cell linesInternational Journal of Cancer, 1993
- CIS‐diamminedichloroplatinum(II) inhibits p34cdc2 protein kinase in human lung‐cancer cellsInternational Journal of Cancer, 1993
- p53-dependent apoptosis modulates the cytotoxicity of anticancer agentsCell, 1993
- Binding activities ofcis-platin-damage-recognition proteins in human tumour cell linesInternational Journal of Cancer, 1993
- Regulation of HSP60 mRNA expression in a human ovarian carcinoma cell lineCancer Chemotherapy and Pharmacology, 1993
- ERCC1 and ERCC2 Expression in Malignant Tissues From Ovarian Cancer PatientsJNCI Journal of the National Cancer Institute, 1992
- Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell lines.Molecular and Cellular Biology, 1992
- The response to chemotherapy of a variety of human tumour xenograftsBritish Journal of Cancer, 1983